This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sirna Therapeutics, Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Joseph D Armstrong: Innovator in Pharmaceutical Chemistry
Introduction
Joseph D Armstrong is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of novel crystalline forms of phosphoric acid salts, particularly in relation to diabetes, obesity, and high blood pressure treatments. His work is characterized by a focus on innovative solutions that address critical health issues.
Latest Patents
Joseph D Armstrong holds a patent titled "Novel Crystalline Forms Of A Phosphoric Acid Salt Of A Dipeptidyl Peptidase-Iv Inhibitor." This invention relates to crystalline anhydrate polymorphs of the dihydrogenphosphate salt of a specific compound. The patent outlines a process for preparing these polymorphs, as well as pharmaceutical compositions that incorporate them. These novel forms are intended for use in treating various health conditions, including diabetes and hypertension.
Career Highlights
Armstrong is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. Despite having no patents listed under his name, his innovative approach and research have had a significant impact on drug formulation and therapeutic applications.
Collaborations
Throughout his career, Joseph D Armstrong has collaborated with esteemed colleagues, including Robert M Wenslow and Alex M Chen. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical research.
Conclusion
Joseph D Armstrong is a dedicated inventor whose work in pharmaceutical chemistry has the potential to improve health outcomes for many individuals. His contributions to the field, particularly in the development of novel crystalline forms for drug applications, highlight the importance of innovation in addressing global health challenges.